Cargando…
COMPARTMENTALIZED CANCER DRUG DISCOVERY TARGETING MITOCHONDRIAL Hsp90 CHAPERONES
There is a plethora of attractive drug targets in cancer, but their therapeutic exploitation proved more difficult than expected, and only rarely truly successful. One possibility not often considered in drug discovery is that cancer signaling pathways are not randomly arranged in cells, but orchest...
Autores principales: | Kang, Byoung Heon, Altieri, Dario C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2766018/ https://www.ncbi.nlm.nih.gov/pubmed/19648961 http://dx.doi.org/10.1038/onc.2009.227 |
Ejemplares similares
-
HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2022) -
Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone
por: Batista, Fernanda A. H., et al.
Publicado: (2020) -
Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis
por: Albakova, Zarema, et al.
Publicado: (2023) -
The chaperone system in cancer therapies: Hsp90
por: Basset, Charbel A., et al.
Publicado: (2023) -
Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer
por: Ruckova, Eva, et al.
Publicado: (2012)